Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 17 results.
User Information
Export Records
  1. 1.   Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens
  2. Ueda, George; Antanasijevic, Aleksandar; Fallas, Jorge A; Sheffler, William; Copps, Jeffrey; Ellis, Daniel; Hutchinson, Geoffrey B; Moyer, Adam; Yasmeen, Anila; Tsybovsky,Yaroslav; Park, Young-Jun; Bick, Matthew J; Sankaran, Banumathi; Gillespie, Rebecca A; Brouwer, Philip Jm; Zwart, Peter H; Veesler, David; Kanekiyo, Masaru; Graham, Barney S; Sanders, Rogier W; Moore, John P; Klasse, Per Johan; Ward, Andrew B; King, Neil P; Baker, David
  3. eLife. 2020, Aug 04; 9: pii: 9:e57659.
  1. 2.   Pharmacophore Refinement Guides the Design of Nanomolar-Range Botulinum Neurotoxin Serotype A Light Chain Inhibitors
  2. Nuss, J. E.; Dong, Y. X.; Wanner, L. M.; Ruthel, G.; Wipf, P.; Gussio, R.; Vennerstrom, J. L.; Bavari, S.; Burnett, J. C.
  3. Acs Medicinal Chemistry Letters. 2010, Oct; 1(7): 301-305.
  1. 3.   Regioselective epoxide ring-opening using boron trifluoride diethyl etherate: DFT study of an alternative mechanism to explain the formation of syn-fluorohydrins
  2. Mendez, P. S.; Cachau, R. E.; Seoane, G.; Ventura, O. N.
  3. Journal of Molecular Structure-theochem. 2009 904(1-3): 21-27.
  1. 4.   Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques
  2. Luckay, A.; Sidhu, M. K.; Kjeken, R.; Megati, S.; Chong, S. Y.; Roopch, V.; Garcia-H, D.; Abdullah, R.; Braun, R.; Montefiori, D. C.; Rosati, M.; Felber, B. K.; Pavlakis, G. N.; Mathiesen, I.; Israel, Z. R.; Eldridge, J. H.; Egan, M. A.
  3. Journal of Virology. 2007, May; 81(10): 5257-5269.
  1. 5.   An enzymatically activated fluorescence probe for targeted tumor imaging
  2. Kamiya, M.; Kobayashi, H.; Hama, Y.; Koyama, Y.; Bernardo, M.; Nagano, T.; Choyke, P. L.; Urano, Y.
  3. Journal of the American Chemical Society. 2007, Apr; 129(13): 3918-3929.
  1. 6.   Combining proteasome inhibition with TNF-related apoptosis-inducing ligand (Apo2L/TRAIL) for cancer therapy
  2. Sayers, T. J.; Murphy, W. J.
  3. Cancer Immunology Immunotherapy. 2006, JAN; 55(1): 76-84.
  1. 7.   Human P2Y(6) receptor: Molecular modeling leads to the rational design of a novel agonist based on a unique conformational preference
  2. Costanzi, S.; Joshi, B. V.; Maddileti, S.; Mamedova, L.; Gonzalez-Moa, M. J.; Marquez, V. E.; Harden, T. K.; Jacobson, K. A.
  3. Journal of Medicinal Chemistry. 2005, DEC 29; 48(26): 8108-8111.
  1. 8.   Binding affinity difference induced by the stereochemistry of the sulfoxide bridge of the cyclic peptide inhibitors of Grb2-SH2 domain: NMR studies for the structural origin
  2. Shi, Y. H.; Song, Y. L.; Lin, D. H.; Tan, J. Z.; Roller, P. P.; Li, Q.; Long, Y. Q.; Song, G. Q.
  3. Biochemical and Biophysical Research Communications. 2005, MAY 20; 330(4): 1254-1261.
  1. 9.   The linkage disequilibrium maps of three human chromosomes across four populations reflect their demographic history and a common underlying recombination pattern
  2. De La Vega, F. M.; Isaac, H.; Collins, A.; Scafe, C. R.; Halldorsson, B. V.; Su, X. P.; Lippert, R. A.; Wang, Y.; Laig-Webster, M.; Koehler, R. T.; Ziegle, J. S.; Wogan, L. T.; Stevens, J. F.; Leinen, K. M.; Olson, S. J.; Guegler, K. J.; You, X. Q.; Xu, L. H.; Hemken, H. G.; Kalush, F.; Itakura, M.; Zheng, Y.; de The, G.; O'Brien, S. J.; Clark, A. G.; Istrail, S.; Hunkapiller, M. W.; Spier, E. G.; Gilbert, D. A.
  3. Genome Research. 2005, APR; 15(4): 454-462.
  1. 10.   Biodiversity: A continuing source of novel drug leads
  2. Cragg, G. M.; Newman, D. J.
  3. Pure and Applied Chemistry. 2005, JAN; 77(1): 7-24.
  1. 11.   The importance of genome architecture in cancer susceptibility - Location, location, location
  2. Reilly, K. M.
  3. Cell Cycle. 2004, NOV; 3(11): 1378-1382.
  1. 12.   (Salen)Mn(III) compound as a nonpeptidyl mimic of catalase: DFT study of the metal oxidation by a peroxide molecule
  2. Abashkin, Y. G.; Burt, S. K.
  3. Journal of Physical Chemistry B. 2004 108(8): 2708-2711.
  1. 13.   Rational design and synthesis of novel dimeric diketoacid-containing inhibitors of HIV-1 integrase: Implication for binding to two metal ions on the active site of integrase
  2. Long, Y. Q.; Jiang, X. H.; Dayam, R.; Sanchez, T.; Shoemaker, R.; Sei, S.; Neamati, N.
  3. Journal of Medicinal Chemistry. 2004 47(10): 2561-2573.
  1. 14.   PCR amplification of DNA containing non-standard base pairs by variants of reverse transcriptase from Human Immunodeficiency Virus-1
  2. Sismour, A. M.; Lutz, S.; Park, J. H.; Lutz, M. J.; Boyer, P. L.; Hughes, S. H.; Benner, S. A.
  3. Nucleic Acids Research. 2004 32(2): 728-735.
  1. 15.   Stabilization from autoproteolysis and kinetic characterization of the human T-cell leukemia virus type 1 proteinase
  2. Louis, J. M.; Oroszlan, S.; Tozser, J.
  3. Journal of Biological Chemistry. 1999 274(10): 6660-6666.
  1. 16.   Escape Mutants of Hiv-1 Proteinase - Enzymic Efficiency and Susceptibility to Inhibition
  2. Wilson, S. I.; Phylip, L. H.; Mills, J. S.; Gulnik, S. V.; Erickson, J. W.; Dunn, B. M.; Kay, J.
  3. Biochimica et Biophysica Acta - Protein Structure & Molecular Enzymology. 1997 1339(1): 113-125.
  1. 17.   Inhibition of Multiple Phases of Human Immunodeficiency Virus Type 1 Replication By a Dithiane Compound That Attacks the Conserved Zinc Fingers of Retroviral Nucleocapsid Proteins
  2. Rice, W. G.; Baker, D. C.; Schaeffer, C. A.; Graham, L.; Bu, M.; Terpening, S.; Clanton, D.; Schultz, R.; Bader, J. P.; Buckheit, R. W.; Field, L.; Singh, P. K.; Turpin, J. A.
  3. Antimicrobial Agents and Chemotherapy. 1997 41(2): 419-426.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel